Search hospitals > Pennsylvania > State College
Mount Nittany Medical Center
Claim this profileState College, Pennsylvania 16803
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Cardiovascular Disease
Conducts research for Lung Cancer
Conducts research for Leukemia
111 reported clinical trials
7 medical researchers
Summary
Mount Nittany Medical Center is a medical facility located in State College, Pennsylvania. This center is recognized for care of Breast Cancer, Cancer, Cardiovascular Disease, Lung Cancer, Leukemia and other specialties. Mount Nittany Medical Center is involved with conducting 111 clinical trials across 221 conditions. There are 7 research doctors associated with this hospital, such as Michelle G. Newman, Ph.D., Kristina S Petersen, PhD, Penny M Kris-Etherton, PhD, and Suzy Scherf, PhD.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage III
Stage II
Stage I
Top PIs
Michelle G. Newman, Ph.D.The Pennsylvania State University5 years of reported clinical research
Studies Anxiety Disorders
Studies Generalized Anxiety Disorder
2 reported clinical trials
4 drugs studied
Kristina S Petersen, PhDPenn State University2 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Penny M Kris-Etherton, PhDPenn State University2 years of reported clinical research
Studies Cardiovascular Disease
1 reported clinical trial
1 drug studied
Suzy Scherf, PhDPennsylvania State University4 years of reported clinical research
Studies Autism Spectrum Disorder
Studies Autism
1 reported clinical trial
2 drugs studied
Clinical Trials running at Mount Nittany Medical Center
Non-Small Cell Lung Cancer
Lung Cancer
Kidney Stones
Obesity
Childhood Obesity
Underage Drinking
Cancer
ALK Gene Rearrangement
Peripheral Arterial Disease
Binge Drinking
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mount Nittany Medical Center?
Mount Nittany Medical Center is a medical facility located in State College, Pennsylvania. This center is recognized for care of Breast Cancer, Cancer, Cardiovascular Disease, Lung Cancer, Leukemia and other specialties. Mount Nittany Medical Center is involved with conducting 111 clinical trials across 221 conditions. There are 7 research doctors associated with this hospital, such as Michelle G. Newman, Ph.D., Kristina S Petersen, PhD, Penny M Kris-Etherton, PhD, and Suzy Scherf, PhD.